EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabolic liver disease

Marta B Afonso iD, Tawhidul Islam, Julie Magusto, Ricardo Amorim, Véronique Lenoir, Rui F Simões, José Teixeira, Liana C Silva, Dominique Wendum, Isabelle Jéru, Corinne Vigouroux, Rui E Castro und 5 weitere

Hepatology · 2023-04 · 77 (4) · 1319-1334

DOI: 10.1002/hep.32756 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hepatology, online erschienen am 11.10.2022. Verfasst von Marta B Afonso und 16 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy , Universidade de Lisboa , Lisbon , Portugal. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Lipodystrophy, Familial Partial. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims: Receptor‐interacting protein kinase 3 (RIPK3) mediates NAFLD progression, but its metabolic function is unclear. Here, we aimed to investigate the role of RIPK3 in modulating mitochondria function, coupled with lipid droplet (LD) architecture in NAFLD. Approach and Results: Functional studies evaluating mitochondria and LD biology were performed in wild‐type (WT) and Ripk3 −/− mice fed a choline‐deficient, amino acid‐defined (CDAA) diet for 32 and 66 weeks and in CRISPR‐Cas9 Ripk3 ‐null fat‐loaded immortalized hepatocytes. The association between hepatic perilipin (PLIN) 1 and 5, RIPK3, and disease severity was also addressed in a cohort of patients with NAFLD and in PLIN1 ‐associated familial partial lipodystrophy. Ripk3 deficiency rescued impairment in mitochondrial biogenesis, bioenergetics, and function in CDAA diet–fed mice and fat‐loaded hepatocytes. Ripk3 deficiency was accompanied by a strong upregulation of antioxidant systems, leading to diminished oxidative stress upon fat loading both in vivo and in vitro. Strikingly, Ripk3 −/− hepatocytes displayed smaller size LD in higher numbers than WT cells after incubation with free fatty acids. Ripk3 deficiency upregulated adipocyte and hepatic levels of LD‐associated proteins PLIN1 and PLIN5. PLIN1 upregulation controlled LD structure and diminished mitochondrial stress upon free fatty acid overload in Ripk3 −/− hepatocytes and was associated with diminished human NAFLD severity. Conversely, a pathogenic PLIN1 frameshift variant was associated with NAFLD and fibrosis, as well as with increased hepatic RIPK3 levels in familial partial lipodystrophy. Conclusions: Ripk3 deficiency restores mitochondria bioenergetics and impacts LD dynamics. RIPK3 inhibition is promising in ameliorating NAFLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseLipodystrophy, Familial PartialHumansMiceAnimalsLipid DropletsLiverHepatocytesEnergy MetabolismMitochondriaReceptor-Interacting Protein Serine-Threonine KinasesAcetamides

Substanzen

Receptor-Interacting Protein Serine-Threonine KinasesCDAAAcetamidesRIPK3 protein, humanRipk3 protein, mouse

Autor:innen und Institutionen

  • Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy , Universidade de Lisboa , Lisbon , Portugal.
  • Institute of Cardiometabolism and Nutrition , Paris , France.
  • Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine , Paris , France.
  • CNC - Center for Neuroscience and Cell Biology , University of Coimbra , Coimbra , Portugal.
  • Université de Paris, Institut Cochin, INSERM, CNRS , Paris , France.
  • Service d'Anatomo-Pathologie, Service d'Hépatologie , Centre de Référence Maladie Rare Maladies Inflammatoires des Voies Biliaires-Hépatites Auto-immunes , Paris , France.

ORCID-Profile: Marta B Afonso, Paulo J Oliveira, Vlad Ratziu

Zitieren

APA

Afonso, M. B., Islam, T., Magusto, J., Amorim, R., Lenoir, V., Simões, R. F., Teixeira, J., Silva, L. C., Wendum, D., Jéru, I., Vigouroux, C., Castro, R. E., Oliveira, P. J., Prip-Buus, C., Ratziu, V., Gautheron, J., & Rodrigues, C. M. P. (2023). RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabolic liver disease. Hepatology, 77(4), 1319-1334. https://doi.org/10.1002/hep.32756

Vancouver

Afonso MB, Islam T, Magusto J, Amorim R, Lenoir V, Simões RF, et al. RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabolic liver disease. Hepatology. 2023;77(4):1319-1334. doi:10.1002/hep.32756

BibTeX
@article{Afonso2023,
  author = {Afonso, Marta B and Islam, Tawhidul and Magusto, Julie and Amorim, Ricardo and Lenoir, Véronique and Simões, Rui F and Teixeira, José and Silva, Liana C and Wendum, Dominique and Jéru, Isabelle and Vigouroux, Corinne and Castro, Rui E and Oliveira, Paulo J and Prip-Buus, Carina and Ratziu, Vlad and Gautheron, Jérémie and Rodrigues, Cecília M P},
  title = {RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabolic liver disease},
  journal = {Hepatology},
  year = {2023},
  volume = {77},
  number = {4},
  pages = {1319--1334},
  doi = {10.1002/hep.32756}
}
Kostenlos starten →